{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.347","meta":{"versionId":"4","lastUpdated":"2023-04-03T14:03:52.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.347","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.347"}],"version":"20170429","name":"GnRHAntagonist","title":"GnRH Antagonist","status":"active","experimental":false,"date":"2017-04-29T01:00:03-04:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1812348","display":"degarelix Injection [Firmagon]"},{"code":"475230","display":"degarelix"},{"code":"835863","display":"degarelix acetate"},{"code":"858122","display":"Firmagon"}]}]},"expansion":{"identifier":"urn:uuid:68eace5e-452f-4f8a-ba38-651248a59549","timestamp":"2023-12-10T21:38:33-05:00","total":4,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1812348","display":"degarelix Injection [Firmagon]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"475230","display":"degarelix"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"835863","display":"degarelix acetate"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"858122","display":"Firmagon"}]}}